Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.30 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6319640 | 0.94 | ANPEP (0.41) | MDM4ANPEPALDH1A1KDM4ECYP1A1 | |
| SCHEMBL24520496 | 0.87 | ANPEP (0.37) | ANPEPALDH1A1KDM4ECYP1A2TRPA1 | |
| SCHEMBL17613407 | 0.82 | POLB (0.35) | ANPEPALDH1A1KDM4ECYP2A6MAOA | |
| SCHEMBL5356716 | 0.82 | ESR1 (0.36) | MDM4ANPEPALDH1A1KDM4E | |
| SCHEMBL5680176 | 0.71 | ANPEP (0.37) | MDM4ANPEPALDH1A1KDM4EMEN1 | |
| SCHEMBL5066101 | 0.70 | MAOB (0.49) | ALDH1A1KDM4ECYP1A1CYP1A2CYP1B1 | |
| SCHEMBL29540307 | 0.69 | MDM4 (0.41) | MDM4ALDH1A1KDM4ETSHRCYP2A6 | |
| SCHEMBL5353222 | 0.69 | ALDH1A1 (0.36) | ALDH1A1KDM4ETRPA1TSHR | |
| SCHEMBL8372675 | 0.69 | ALDH1A1 (0.48) | ANPEPALDH1A1KDM4ECYP1A2TRPA1 | |
| SCHEMBL149913 | 0.69 | MDM4 (0.41) | MDM4ALDH1A1KDM4ETSHRCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7196225-B2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| US-7196225-B2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| US-7196225-B2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| EP-1090911-B1 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORP (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20060178522-A1 | BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | JOLED INC. (JP) | 2006-08-10 | — | — | US | disclosed |
| US-7049470-B1 | Bis (aminostyryl) anthracene compound, synthesis is intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2006-05-23 | — | — | US | disclosed |
| EP-1090911-A2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2001-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178522-A1 | BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | AASDHPPT, DDC, AADAT | MDM4 309/4885ANPEP 250/4885ALDH1A1 782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.